Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.

Alisa Nobee, Mei Xu, Anjali Seth, Yuan Rong

Research output: Contribution to journalArticlepeer-review


Oncogenic Yes-associated protein (YAP) 1 fusions have been recently identified in several cases of meningioma mostly involving pediatric patients. The meningiomas harboring YAP1-MAML2, which is the most frequent fusion subtype, exhibit activated YAP1 signaling and share similarities with NF2 (neurofibromatosis type 2 gene) mutant meningiomas. We reported a rare case of atypical intraparenchymal meningioma with YAP1-MAML2 fusion in a 20-year-old male. The patient presented with an episode of seizure without a medical history. MRI revealed a lesion in the right temporal lobe without extra-axial involvement. The radiological and morphological findings, however, were indistinctive from other intracranial diseases, e.g., vascular malformation and glioma. Immunohistochemical results confirmed the presence of abundant meningothelial cells in the tumor and indicated brain invasion, supporting the diagnosis of atypical intraparenchymal meningioma. Targeted RNA fusion analysis further identified a YAP1-MAML2 rearrangement in the tumor. Non-dural-based intraparenchymal meningiomas are uncommon, and the careful selection of specific tumor markers is crucial for an accurate diagnosis. Additionally, the detection of the fusion gene provides valuable insights into the oncogenic mechanism of meningioma.

Original languageAmerican English
JournalInternational Journal of Molecular Sciences
StatePublished - Aug 15 2023


  • Adaptor Proteins
  • Adult
  • Child
  • Genes
  • Humans
  • Male
  • Meningeal Neoplasms
  • Meningioma
  • Neurofibromatosis 2
  • Signal Transducing
  • Signal Transduction
  • Trans-Activators
  • Transcription Factors
  • Young Adult


  • Medicine and Health Sciences

Cite this